Importantly, treatment was associated with a reduction in pro-inflammatory cytokines, including MCP-1, IP-10, and MIP-1β, as well as an increase in decorin expression within nevus tissue, a potential biomarker of tumor suppression. Here, CXCL10 is linked to neoplasm.